Cargando…
RON is not a prognostic marker for resectable pancreatic cancer
BACKGROUND: The receptor tyrosine kinase RON exhibits increased expression during pancreatic cancer progression and promotes migration, invasion and gemcitabine resistance of pancreatic cancer cells in experimental models. However, the prognostic significance of RON expression in pancreatic cancer i...
Autores principales: | Tactacan, Carole M, Chang, David K, Cowley, Mark J, Humphrey, Emily S, Wu, Jianmin, Gill, Anthony J, Chou, Angela, Nones, Katia, Grimmond, Sean M, Sutherland, Robert L, Biankin, Andrew V, Daly, Roger J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532183/ https://www.ncbi.nlm.nih.gov/pubmed/22958871 http://dx.doi.org/10.1186/1471-2407-12-395 |
Ejemplares similares
-
The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling
por: Tactacan, Carole M., et al.
Publicado: (2015) -
Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)
por: Zou, Yi, et al.
Publicado: (2013) -
Clinical and molecular characterization of HER2 amplified-pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2013) -
PINA v2.0: mining interactome modules
por: Cowley, Mark J., et al.
Publicado: (2012) -
Novel cancer drivers: mining the kinome
por: Biankin, Andrew V, et al.
Publicado: (2013)